Advertisement





Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 51:546-551, doi:10.1016/j.jacc.2007.08.061
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, C. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gibson, C. M.

CLINICAL RESEARCH: MYOCARDIAL INFARCTION

Association of Impaired Thrombolysis In Myocardial Infarction Myocardial Perfusion Grade With Ventricular Tachycardia and Ventricular Fibrillation Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction

C. Michael Gibson, MS, MD, FACC*,*, Yuri B. Pride, MD{ddagger}, Jacqueline L. Buros, BA*, Erin Lord, BA*, Amy Shui, MA*, Sabina A. Murphy, MPH*, Duane S. Pinto, MD, FACC{ddagger}, Peter J. Zimetbaum, MD, FACC{ddagger}, Marc S. Sabatine, MD, MPH, FACC{dagger}, Christopher P. Cannon, MD, FACC{dagger}, Mark E. Josephson, MD, FACC{ddagger} for the TIMI Study Group

* TIMI Study Group, Beth Israel Deaconess Medical Center, Boston, Massachusetts
{dagger} Brigham & Women’s Hospital, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts
{ddagger} Division of Cardiology and Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Manuscript received June 18, 2007; revised manuscript received August 24, 2007, accepted August 27, 2007.

* Reprint requests and correspondence: Dr. C. Michael Gibson, Director, TIMI Data Coordinating Center, 350 Longwood Avenue, First Floor, Boston, Masschusetts 02115. (Email: mgibson{at}perfuse.org).

Objectives: The goal of this analysis was to evaluate the association of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grade (TMPG) with sustained ventricular tachycardia (VT) or ventricular fibrillation (VF).

Background: Impaired TMPG after successful restoration of epicardial flow among patients treated with fibrinolytic therapy for ST-segment elevation myocardial infarction (STEMI) has been associated with adverse clinical outcomes, but its relationship to VT/VF has not been evaluated.

Methods: In the CLARITY-TIMI 28 (Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction 28) study, 3,491 patients underwent angiography a median of 3.5 days after fibrinolytic administration for STEMI; TMPG was assessed, and its association with VT/VF was evaluated.

Results: We observed VT/VF in 4.8% of patients. Impaired myocardial perfusion (TMPG 0/1/2) was associated with an increased incidence of VT/VF (7.1% vs. 2.6% with TMPG 3; log-rank p < 0.001). Among patients with restoration of normal epicardial flow (Thrombolysis In Myocardial Infarction flow grade 3), the incidence of VT/VF was increased among patients with impaired TMPG (4.7% vs. 2.7%; p = 0.02). Among patients with left ventricular ejection fraction ≥30%, impaired TMPG remained associated with an increased incidence of VT/VF (4.7% vs. 2.5%; p = 0.03). We found that VT/VF was associated with increased mortality (25.2% vs. 3.5%; p < 0.0001). Furthermore, among patients with VT/VF, impaired TMPG was associated with increased mortality (17.1% vs. 2.3%; p = 0.02). All but 1 death among patients who had VT/VF were among patients with impaired myocardial perfusion.

Conclusions: Despite restoration of normal epicardial flow or a left ventricular ejection fraction ≥30%, impaired myocardial perfusion on angiography 3.5 days after fibrinolytic administration for STEMI is associated with an increased incidence of VT/VF.

Abbreviations and Acronyms
  MRI = magnetic resonance imaging
  PCI = percutaneous coronary intervention
  SCD = sudden cardiac death
  STEMI = ST-segment elevation myocardial infarction
  TFG = Thrombolysis In Myocardial Infarction flow grade
  TMPG = Thrombolysis In Myocardial Infarction myocardial perfusion grade
  VF = ventricular fibrillation
  VT = ventricular tachycardia




This article has been cited by other articles:


Home page
JAMAHome page
R. H. Mehta, A. Z. Starr, R. D. Lopes, J. S. Hochman, P. Widimsky, K. S. Pieper, P. W. Armstrong, C. B. Granger, and for the APEX AMI Investigators
Incidence of and Outcomes Associated With Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention
JAMA, May 6, 2009; 301(17): 1779 - 1789.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Majidi, A. S. Kosinski, S. M. Al-Khatib, M. E. Lemmert, L. Smolders, A. van Weert, J. H.C. Reiber, D. Tzivoni, F. W.H.M. Bar, H. J.J. Wellens, et al.
Reperfusion ventricular arrhythmia 'bursts' predict larger infarct size despite TIMI 3 flow restoration with primary angioplasty for anterior ST-elevation myocardial infarction
Eur. Heart J., April 1, 2009; 30(7): 757 - 764.
[Abstract] [Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement